Tags: Conference

blog

Two Decades of Research: The ADDF's 19th International Conference on Alzheimer’s Drug Discovery

Researchers shared updates on their approaches to developing Alzheimer's treatments at our annual conference.

announcements

$2.5 Million in New Funding Exemplifies ADDF’s Strategy

We announce $2.5 million in new funding, which reflects the comprehensive nature of our strategy to prevent and treat Alzheimer’s disease. 

blog

ADDF Grantees Headline NIH Alzheimer's Summit

ADDF-supported research was at the forefront of the Summit and the National Plan to Address Alzheimer's.

blog

CTAD Conference Highlights Our Funded Research

Wednesday marked the beginning of National Alzheimer's Disease Awareness Month and the 10th Clinical Trials on Alzheimer's Disease conference, which featured a record amount of research we supported.

announcements

18th Annual Conference on Alzheimer's Drug Discovery Showcases Non-Amyloid Research

Nearly 200 academic and industry researchers came together to share updates on innovative preclinical and clinical-stage Alzheimer’s disease research at the 18th Annual Conference on Alzheimer's Drug Discovery.

blog

Driving Innovation in Alzheimer's Therapies

At our 18th Annual Conference on Alzheimer’s Drug Discovery in Jersey City, the impact of our approach will take center stage.

blog

Three Themes Emerge at BIO2017

Dr. Lauren Friedman details the three topics that dominated discussions at this year's BIO International Convention.

blog

Looking Ahead on World Alzheimer's Day

On World Alzheimer’s Day, we celebrate the progress made toward finding effective treatments and look toward the future. 

blog

A Banner Year for Alzheimer's Drug Discovery

In 2014, we had a transformative year, advancing drugs for Alzheimer's, supporting the best science, and ensuring people have information to protect their brain health.

blog

New Drug Targets Are Highlight of Alzheimer's Conference

Presenters at our recent conference shared exciting progress on new Alzheimer's drug targets and biomarkers.